⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL716843 | 1.00 | SMN1; SMN2 (0.41) | — | |
| SCHEMBL161931 | 1.00 | — | — | |
| SCHEMBL43661 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL3947878 | 0.97 | SMN1; SMN2 (0.39) | — | |
| Hydrochloric Acid SCHEMBL6780690 | 0.97 | SMN1; SMN2 (0.39) | — | |
| Hydrochloric Acid SCHEMBL3947884 | 0.97 | SMN1; SMN2 (0.39) | — | |
| Valine SCHEMBL28845417 | 0.86 | SLC7A5 (0.65) | — | |
| Trifluoroacetic Acid SCHEMBL30405351 | 0.86 | MMP1 (0.36) | — | |
| SCHEMBL5490834 | 0.83 | TP53 (0.36) | — | |
| SCHEMBL5490842 | 0.83 | TP53 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9123 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083866-A1 | COMPOSITIONS TARGETING ENDOTHELIAL CELLS AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-03-26 | — | — | US | claimed |
| US-20260035408-A1 | WKYMVm peptide analogues having six residues and uses thereof | RESEARCH & BUSINESS FOUND SUNGKYUNKWAN UNIV (KR) | 2026-02-05 | — | — | US | claimed |
| EP-4658676-A2 | ANTI-CDH17 ANTIBODIES AND USE OF THE SAME | Bighat Biosciences, Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4635516-A2 | ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES | Pfizer Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| WO-2025199636-A1 | TARGETED RADIOLIGAND COMPOUNDS AND USES THEREOF | MCMASTER UNIVERSITY (CA) | 2025-10-02 | — | — | WO | claimed |
| US-20250268982-A1 | COMPOSITIONS AND METHODS FOR TREATMENT AND/OR PROPHYLAXIS OF PROTEINOPATHIES | REGAIN THERAPEUTICS SWEDEN AB (SE) | 2025-08-28 | — | — | US | claimed |
| US-20250161408-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2025-05-22 | — | — | US | claimed |
| US-20250111889-A1 | DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES | UNIVERSITY OF WASHINGTON | 2025-04-03 | — | — | US | claimed |
| US-4997648-A | Bactericide, antiinflammatory, immunosuppressive | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1991-03-05 | — | — | US | claimed |
| EP-0378604-A1 | 1,1-DIOXO-CEPHEM-4-CARBOTHIOLIC ACID DERIVATIVES. | ERBA CARLO SPA (IT) | 1990-07-25 | — | — | EP | claimed |
| EP-0352092-A2 | Novel antibiotics R106 | TAKARA SHUZO CO. LTD. (JP) | 1990-01-24 | — | — | EP | claimed |
| WO-1989010926-A1 | 1,1-DIOXO-CEPHEM-4-CARBOTHIOLIC ACID DERIVATIVES | FARMITALIA CARLO ERBA S.R.L. (IT) | 1989-11-16 | — | — | WO | claimed |
| EP-0300784-A2 | Peptides | BTG INTERNATIONAL LIMITED (GB) | 1989-01-25 | — | — | EP | claimed |
| EP-0300785-A2 | Cyclosporins | BTG INTERNATIONAL LIMITED (GB) | 1989-01-25 | — | — | EP | claimed |
| US-4522812-A | Novel physiologically active substance K-4, a process for preparation thereof and a pharmaceutical composition containing the same | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1985-06-11 | — | — | US | claimed |
| US-4336249-A | MYCOPLANECIN PRODUCT CULTIVATED FORM ACTINOPLANES | SANKYO COMPANY LIMITED (JP) | 1982-06-22 | — | — | US | claimed |
| US-4118482-A | Process for treating neoplastic disease with azetomicins | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1978-10-03 | — | — | US | claimed |
| US-4053460-A | ACTINOMYCIN ANTIBIOTIC ANALOGUES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1977-10-11 | — | — | US | claimed |